Literature DB >> 16425817

Oxidative stress in chronic kidney disease.

Cathi J Martin1, Catherine M Goeddeke-Merickel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16425817

Source DB:  PubMed          Journal:  Nephrol Nurs J        ISSN: 1526-744X            Impact factor:   0.959


× No keyword cloud information.
  6 in total

1.  Inhibition of porcine kidney betaine aldehyde dehydrogenase by hydrogen peroxide.

Authors:  Jesús A Rosas-Rodríguez; Ciria G Figueroa-Soto; Elisa M Valenzuela-Soto
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

2.  Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK).

Authors:  Jamison Chang; Jennie Z Ma; Qing Zeng; Sylvia Cechova; Adam Gantz; Caroline Nievergelt; Daniel O'Connor; Michael Lipkowitz; Thu H Le
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-05

3.  Renal protective effect of hesperidin on gentamicin-induced acute nephrotoxicity in male Wistar albino rats.

Authors:  Ramaswamy Anandan; Perumal Subramanian
Journal:  Redox Rep       Date:  2012-08-09       Impact factor: 4.412

4.  Oxidant-induced atrogin-1 and transforming growth factor-beta1 precede alcohol-related myopathy in rats.

Authors:  Jeffrey S Otis; Lou Ann S Brown; David M Guidot
Journal:  Muscle Nerve       Date:  2007-12       Impact factor: 3.217

5.  α-Lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway.

Authors:  Hyunsoo Kim; Han-Jong Kim; Kyunghee Lee; Jin-Man Kim; Hee Sun Kim; Jae-Ryong Kim; Chae-Myeong Ha; Young-Keun Choi; Sun Joo Lee; Joon-Young Kim; Robert A Harris; Daewon Jeong; In-Kyu Lee
Journal:  J Cell Mol Med       Date:  2012-02       Impact factor: 5.310

6.  Mice Exposed to Chronic Intermittent Hypoxia Simulate Clinical Features of Deficiency of both Qi and Yin Syndrome in Traditional Chinese Medicine.

Authors:  Chengzhi Chai; Junping Kou; Danni Zhu; Yongqing Yan; Boyang Yu
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-08       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.